Get the Stockscreener App
0.5499
3.54%
-0.0202
Why is Allovir Inc (ALVR) Stock down?
We've noticed a 5.01% decline in Allovir Inc (ALVR) stock during the 2024-11-19 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
22 Dec, 2023:
AlloVir Inc (ALVR) stock dropped by 67.15% due to a critical announcement made by the company regarding the outcome of its Phase 3 clinical trials. AlloVir announced that it had failed in multiple Phase 3 clinical trials, with separate futility analyses indicating that the drug was unlikely to achieve its primary endpoints. In response to these findings, AlloVir made the decision to discontinue all three Phase 3 trials and revealed its intention to assess various options for the program. The announcement of these unfavorable trial results had a substantial negative impact on AlloVir's stock price on that day.
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):